Researchers sought to determine whether combining memantine with a cholinesterase inhibitor produced early and consistent improvements in cognition for patients with moderate to severe Alzheimer ...

Combining memantine with an older, widely used AD drug further improves measures of cognition, global well-being, activities of daily living, and behavior in people with moderate to severe AD, ...

Aging Health. 2012;8(3):233-237. The authors also raise the question as to whether combination therapy, by adding memantine to a cholinesterase inhibitor, as has been recommended for ...

March 18, 2009 (Santa Ana Pueblo, New Mexico) — Memantine, a drug currently approved for the treatment of moderate-to-severe Alzheimer's disease (AD) that is under investigation as adjunctive ...

You have full access to this article via your institution. In June 2000, Merz and Forest announced a development and marketing agreement for memantine in the United States for the treatment of AD and ...

Treating patients with moderately severe to severe Alzheimer’s disease with the drug memantine is more cost-effective than no therapy, according to a European study in the journal Clinical Drug ...

Association of anticonvulsant prophylaxis in patients with primary and metastatic brain tumors and 1-year overall survival: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from ...

Alzheimer’s dementia represents organ failure of the brain. It denotes a clinical milestone that is the result of a pathological process, Alzheimer’s disease (AD), which over 1 or more decades has ...

Every 69 seconds, a person in the United States develops Alzheimer’s disease (AD). By 2050, this rate is expected to double. Total direct costs of AD and dementia (AD/D) are estimated at $183 billion, ...

Sequential therapy with the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas: An Adult Brain Tumor Consortium phase I study (ABTC1101) ...

(CN) - Actavis cannot maintain its billion-dollar monopoly on an Alzheimer's drug by forcing Alzheimer's patients to switch to a freshly patented version before a generic can enter the market, a 2nd ...

“A balanced and skillful approach to life, taking care to avoid extremes, becomes a very important factor in conducting one's everyday existence. It is important in all aspects of life.” —The Dalai ...